TRPC1 and metabolic syndrome: Mechanistically, spironolactone counteracted the aldosterone-induced rise in monocyte adhesion in coronary arteries of the pigs by decreasing the expression of TRPC1 and TRPC6 channels in coronary arteries, reducing MetS-associated atherosclerosis, endothelial dysfunction and vasoconstriction [86].